Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000598483 | SCV000702007 | uncertain significance | not provided | 2016-10-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000598483 | SCV001982083 | uncertain significance | not provided | 2021-09-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002491173 | SCV002777873 | uncertain significance | Greig cephalopolysyndactyly syndrome; Pallister-Hall syndrome; Polysyndactyly 4; Polydactyly, postaxial, type A1 | 2022-04-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002530989 | SCV003242991 | likely benign | Greig cephalopolysyndactyly syndrome; Pallister-Hall syndrome | 2022-08-24 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000598483 | SCV003816887 | uncertain significance | not provided | 2021-11-30 | criteria provided, single submitter | clinical testing |